4//SEC Filing
Thomson Mary Christina 4
Accession 0001209191-22-005434
CIK 0001290149other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:47 PM ET
Size
11.7 KB
Accession
0001209191-22-005434
Insider Transaction Report
Form 4
Thomson Mary Christina
General Counsel, CCO & Sec'y
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-26+2,000→ 0 totalExercise: $13.04Exp: 2030-07-28→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2022-01-26$13.04/sh+2,000$26,080→ 2,000 total - Sale
Common Stock
2022-01-26$29.00/sh−2,000$58,000→ 0 total - Award
Stock Option (Right to Buy)
2022-01-28+12,250→ 12,250 totalExercise: $12.15From: 2022-01-28Exp: 2030-08-12→ Common Stock (12,250 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 21, 2022. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on April 26, 2022. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- [F2]On July 28, 2021, the option vested as to 25% of the total shares granted on July 28, 2020, with the remaining shares from that grant vesting in equal monthly installments over the following 36 months, with 100% of the total shares vested on July 28, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]On August 12, 2020, the Reporting Person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 12,250 shares.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001295674
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:47 PM ET
- Size
- 11.7 KB